abstract |
The present invention relates to novel sulfonamide drugs of formula I, wherein R 1 , R 2 , R 3 , R 4 , R 5 , Ar, Ar 1 , Ar 2 , n, o and p are as described in the specification and claims. stated. These compounds are orexin receptor antagonists and are useful in the treatment of conditions in which the orexin pathway is involved. |